Erik Brändt Öfverholm

Partner
Head of Competition, Sweden
Erik Brändt Öfverholm
Location
Stockholm
Language
English, Swedish

Erik Brändt Öfverholm specializes in competition law and the field of foreign direct investment (FDI) control. He heads DLA Piper's Competition & Public Procurement group in Sweden. Before joining DLA Piper, he was the head of EU and Competition Law at another international law firm in Stockholm. Erik also has a background at the Swedish Competition Authority.


Erik assists clients on all competition law-related matters, such as strategic merger control advice, litigation and matters before competition authorities, compliance, state aid and public procurement. Erik is ranked as a "Rising Star" by Legal 500.

Qualifications
Professional background
Partner, Head of Competition & Procurement, Advokatfirma DLA Piper Sweden KB
2021
Head of EU & Competition, Stockholm, Baker McKenzie
2017-2021
Advokat / Senior associate, Lindahl
2010-2017
Case officer, Swedish Competition Authority
2008-2010
Education
Master of laws (LL:M), University of Uppsala
2009
Competition law , Stockholm University
2008
International legal studies programme , University of Antwerp
2007
Membership
Member of the Swedish Bar Association
Experience
Selected experience
Advised a leading private equity player with the merger control aspects of their acquisition and combination of two lending comparison companies.
Successfully represented a leading fintech in an abuse of dominance probe by the Swedish Competition Authority.
Successfully defended a multinational musical instruments manufacturer in a pricing probe by the Swedish Competition Authority.
Successfully defended a media operator in a probe by the Swedish Competition Authority.
Successfully defended a leading ports operator in an abuse claim.
Defended a Nordic energy company in a probe by the Swedish Competition Authority.
Ranking
Chambers
Ranked in Chambers in Competition/ European Law 2023
Legal 500
Ranked in Legal 500 in EU and Competition 2023
Ranked in Legal 500 in Healthcare and Life Sciences 2023